Biography
Mr. Kalb is a member of Sidley Austin’s Executive Committee and leader of its COVID-19 Task Force. He formerly served as the global leader of the Sidley Austin Healthcare and FDA group. Mr. Kalb brings an uncommon clinical perspective, grounded in his experience as an attending physician at the Memorial Sloan Kettering Cancer Center, to bear in his work for a wide range of health care clients. He has successfully represented many of the world’s leading drug, biotech, and device manufacturers as well as hospitals and other providers in criminal, civil, and administrative enforcement actions involving health care fraud and abuse and off-label promotion. He has led teams that defended numerous matters and negotiated groundbreaking settlement agreements and corporate integrity agreements.
In addition to his work on enforcement matters, Mr. Kalb counsels private equity firms on life sciences investments and advises both boards of directors and companies on compliance issues. He is also a co-founder of the Medical Information Working Group, a coalition of life sciences companies dedicated to rationalizing the rules governing the exchange of scientific information.
Mr. Kalb has written numerous articles in legal, medical, and industry publications. He has focused, in particular, on the fiduciary obligations of directors to oversee mission-critical risks. He speaks regularly at industry conferences and has also lectured on fraud and abuse issues at the Justice Department’s National Training Center. He was a visiting lecturer at Yale College in medicine, law, and public policy.
Bio last updated in October 2022.